From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
Graft survival rate
rATG
IL2-RA
P
Year 1
37 (100.0)
123 (97.6)
1.000
Year 2
21 (100.0)
73 (96.1)
Year 3
10 (100.0)
44 (93.6)